| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Nonalcoholic fatty liver disease 0.5864476698089632 3.832742627923885 0.0001267225135286 0.074158449224635 0.0290249359065486 54 Q9UDW1,P13073,P14406,P21912,Q96GC9,P31751,O14949,P00403,Q9P0J0,O43676,Q9Y6M9,P20674,Q86Y39,O96000 14 |
| Electron transport chain oxphos system in mitochondria 0.5832491047679622 3.8025486277400846 0.0001432151442757 0.0833971921047899 0.0290249359065486 54 P14406,P21912,O14949,O43676,Q9Y6M9,P24539,P00846,O96000,P51970,Q9UDW1,Q7KZN9,O75880,P20674,O75306,P03886,P56385,O95168,P00403,P12235,P13073,P12236,O75964 22 |
| Sphingolipid metabolism in senescence 0.7437715943735809 3.0126871704136784 0.0025894569756779 0.7932886233440116 0.1629010289843189 14 Q96G23,Q06136,O15121,Q13510,Q16739,P04062 6 |
| Mitochondrial complex iv assembly 0.7201444147632193 2.9782149165537217 0.0028993260661596 0.8288732296799963 0.1629010289843189 16 Q96I36,P13073,P14406,Q9Y2R0,Q9P0S2,Q7KZN9,P20674,P00403 8 |
| Ferroptosis 0.6410749631322306 2.8244293487632897 0.0047364889374472 0.9442360079499342 0.1629010289843189 22 Q9Y277,P09601,P45880,Q9NZ45,P37268 5 |
| Sphingolipid metabolism integrated pathway 0.8316999575040803 2.794462578827273 0.0051986057048749 0.9579542347897412 0.1629010289843189 9 Q96G23,Q06136,O15121,Q13510,Q16739,Q9NRA0,O95470 7 |
| Sphingolipid metabolism overview 0.8316999575040803 2.794462578827273 0.0051986057048749 0.9579542347897412 0.1629010289843189 9 Q96G23,Q06136,O15121,Q13510,Q16739,Q9NRA0,O95470 7 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.6782814744255131 2.7254873110573845 0.0064206644346642 0.980086358096568 0.1629010289843189 16 O75844,Q9Y2U8,P42166,P11802,P42167,O60725,P55209,P50402 8 |
| Familial partial lipodystrophy fpld 0.8361782426965947 2.7232988183694724 0.0064633567723555 0.9805998697637284 0.1629010289843189 8 O60725,O75844 2 |
| Sphingolipid pathway 0.7627699706692469 2.6593793615742394 0.007828476020139 0.991590908853172 0.1629010289843189 11 Q96G23,Q06136,Q13510,Q16739,P04062,Q9NRA0,O95470 7 |
| Alzheimers disease and mirna effects 0.4251274112886398 2.57909096120878 0.0099060698320918 0.9976490141524954 0.1738116933668198 88 Q9Y277,P51665,O95197,P07384,P49721,P21796,P45880,P16615,P28072,Q14457,Q9NQC3,P20618,P05067,Q96GC9,P12235,P28070,P05141,P31751,Q99436,P28074,P12236,O00487,Q08209 23 |
| Influence of laminopathies on wnt signaling 0.7308490154464061 2.490425596003029 0.0127590207480898 0.999593285296254 0.1801502109862225 11 O60725,O75844 2 |
| Alzheimers disease 0.4129060361306469 2.4369213528889495 0.0148129006820085 0.9998853485658156 0.1916222045672599 86 Q9Y277,P51665,O95197,P07384,P49721,P21796,P45880,P16615,P28072,Q14457,Q9NQC3,P20618,P05067,P12235,P28070,P05141,P31751,Q99436,P28074,P12236,O00487,Q08209 22 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5584245375703595 2.3586520331057117 0.0183414450469536 0.9999870593205312 0.2144538190105352 24 Q16850,Q9BWD1,P37268,Q15392,Q14534,P04035,O95749,Q15800 8 |
| Oxidative phosphorylation 0.517163434798051 2.3343162389222827 0.0195791690481916 0.9999939907771848 0.2204469403944544 31 P51970,P03886,O75306,P56385,P24539,O75964,P56134,Q15904,P06576,O95168,Q9Y6M9,P00846,Q86Y39,O96000 14 |
| Proteoglycan biosynthesis 0.8326498288187258 2.297143128085659 0.0216106061794965 0.999998297310127 0.2346294385202477 6 Q8TB61,Q8NCH0,Q8WVQ1 3 |
| Mitochondrial complex i assembly model oxphos system 0.5090083384165378 2.228721872827378 0.0258324159966159 0.9999998771786586 0.2589878539281425 30 P51970,P03886,Q9NPL8,Q96CU9,O75306,O95168,O43676,Q9Y6M9,Q9P0J0,O96000 10 |
| Oxidation by cytochrome p450 0.8095027684418812 2.1935243091647822 0.0282696251163137 0.999999973218602 0.2692857161045837 6 P00387,Q16850,O43169,Q6UW02 4 |
| Ccl18 signaling pathway 0.6608464493860544 2.1076721492946526 0.0350593579656344 0.9999999996229804 0.3134719065162606 11 Q86UE4,Q96GC9,P00403 3 |
| Metabolism of spingolipids in er and golgi apparatus 0.8540492435479111 2.0688350355266665 0.0385615694875032 0.9999999999586706 0.315311515203085 5 Q06136,O95470,Q16739,Q9NRA0 4 |
| Metapathway biotransformation phase i and ii 0.5472755541425389 2.062602035449437 0.0391504542124983 0.999999999971524 0.315311515203085 20 P21964,Q16850,Q8NCH0,Q7LGA3,P78417,Q6UW02,Q99735 7 |
| Statin inhibition of cholesterol production 0.8525660041530723 2.0625651139961687 0.0391539651247963 0.9999999999715874 0.315311515203085 5 P37268,Q14534,P04035,Q8WTV0 4 |
| Mitochondrial complex iii assembly 0.6703771706067414 2.0598389522545593 0.0394139394003856 0.9999999999758976 0.315311515203085 10 O14949,Q9UDW1 2 |
| Glycerophospholipid biosynthetic pathway 0.729555608972113 2.005207391131546 0.0449408802563027 0.9999999999992782 0.3381278753561811 7 O15228,Q9HCL2,O14735,P48651 4 |
| Mitochondrial immune response to sarscov2 0.6322559817704989 1.946467943156173 0.0515985550416067 0.9999999999999898 0.3647897844801963 11 Q7Z434,Q9Y6M9,Q86UT6,Q99623,Q9BQ95,Q9UHD2,P19838 7 |
| Progeriaassociated lipodystrophy 0.6187652105609787 1.8694353243831785 0.061562273866073 1.0 0.4068463316366567 11 O60725 1 |
| Nucleotidebinding oligomerization domain nod pathway 0.7292909846804316 1.825181890779574 0.0679735856415004 1.0 0.435030948105603 6 Q7L5N1 1 |
| S1p receptor signal transduction 0.6359884315338482 1.791766702581448 0.0731703446644536 1.0 0.4634121828748728 9 P31751,Q13510 2 |
| Copper homeostasis 0.6307057589637861 1.7631084027606396 0.0778822083009709 1.0 0.4831875780305135 9 P35670,P05067,P49841,Q8N668,O43819,O75880 6 |
| Glycerolipids and glycerophospholipids 0.7761609140542437 1.7343442322695808 0.0828570236666943 1.0 0.5011472034718718 5 Q9HCL2,O14735,P48651 3 |
| Endothelin pathways 0.6209549130899128 1.7100059682747084 0.0872647694106807 1.0 0.5151163087543095 9 P16615,P42892,P00403 3 |
| Cholesterol biosynthesis pathway 0.5498760030612884 1.6940745710757914 0.0902511137093644 1.0 0.527621895531669 13 Q16850,Q14534,P37268,Q15800 4 |
| Glycosaminoglycan degradation 0.6841173715286377 1.611792686018931 0.1070070602940467 1.0 0.5657416752937426 6 P06865,P16278,P54802 3 |
| Tyrobp causal network in microglia 0.6781738446611995 1.5834336141218184 0.1133226665291156 1.0 0.5733318175581378 6 Q15418,Q5T1M5 2 |
| Cholesterol biosynthesis with skeletal dysplasias 0.7400438254657643 1.5759229747823311 0.1150435554968631 1.0 0.5733318175581378 5 Q16850,Q14739,Q15392 3 |
| Kennedy pathway from sphingolipids 0.733610204687041 1.5475152744189022 0.1217390441567274 1.0 0.5863378314595028 5 O95470,Q9UG56,P48651,Q9BVG9 4 |
| Vitamin a and carotenoid metabolism 0.7317592279625615 1.5393327146699824 0.1237230911985176 1.0 0.5863378314595028 5 Q8WTV0,P09455 2 |
| Degradation pathway of sphingolipids including diseases 0.6679266647917564 1.534400053074385 0.124931264567931 1.0 0.5863378314595028 6 O43681,P06865,P16278 3 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.6345250427248953 1.5329598568444425 0.1252857461238468 1.0 0.5863378314595028 7 P09601 1 |
| Autophagy 0.5943160449935185 1.495910487718724 0.1346769829213498 1.0 0.589864854818481 8 Q14457,Q9NT62,P42345 3 |
| Triacylglyceride synthesis 0.7015525695128394 1.405260317564174 0.1599438837847375 1.0 0.6199588856053652 5 O15228,Q9HCL2 2 |
| Cellular proteostasis 0.6408562828044988 1.4040985574466924 0.1602895031322544 1.0 0.6199588856053652 6 Q9UHV9,O15212,Q99471,P61758 4 |
| Urea cycle and related diseases 0.872258446947244 1.3835068146442155 0.16650951925266 1.0 0.6199588856053652 2 Q9Y619 1 |
| Nephrotic syndrome 0.4590628003231407 1.2433547999585144 0.2137371186782601 1.0 0.6659951679797733 15 Q14108,Q7Z4L5,O75844 3 |
| Amyotrophic lateral sclerosis als 0.5113213745386594 1.2366095105108634 0.2162320874067469 1.0 0.6659951679797733 11 Q9BUN8,P07197,Q08209 3 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.5110286316327982 1.2348493298390506 0.2168865843092025 1.0 0.6659951679797733 11 O95140,Q8TB36,Q9NR77 3 |
| Adipogenesis 0.4491482389361685 1.2019802776022306 0.2293711694316762 1.0 0.6795466503202524 16 O75376,Q9NZ45,O75844 3 |
| Vitamin d metabolism 0.845333768993348 1.197062925952075 0.2312820289607011 1.0 0.6795466503202524 3 P04062 1 |
| Eicosanoid synthesis 0.8245406046235928 1.1847782302612424 0.2361051421080136 1.0 0.6803408834202477 2 P09960 1 |
| Camkk2 pathway 0.483923309098879 1.1647415720041556 0.2441236158770783 1.0 0.693584852585344 12 P09601,O76024 2 |
| Reninangiotensinaldosterone system raas 0.8306866085459437 1.140528329081626 0.254066257281335 1.0 0.7044481848259655 3 Q13555 1 |
| Omega9 fatty acid synthesis 0.5550879215937009 1.1256250131887688 0.260324275986812 1.0 0.7052508361310216 7 O00767,Q86SK9,O95864,P33121 4 |
| Hostpathogen interaction of human coronaviruses autophagy 0.7409716697161324 1.121325912512439 0.2621491594829126 1.0 0.7052508361310216 4 Q14457,Q9NT62 2 |
| Nanomaterial induced apoptosis 0.5768185623159572 1.0930456801355448 0.27437374386142 1.0 0.7278580526336708 6 Q9NR28,O95831 2 |
| Omega3 omega6 fatty acid synthesis 0.5585976266930133 1.004457830407951 0.3151579874430128 1.0 0.7757735075520316 6 Q15067,O15254,P33121 3 |
| Vitamin b12 disorders 0.6979563882172928 0.947713223319753 0.3432754673035068 1.0 0.8089592407772562 4 Q96EY8 1 |
| Genes related to primary cilium development based on crispr 0.4007952289587675 0.9104249298927 0.3625984552496448 1.0 0.8350752302719093 18 A0AVF1,O95684,Q10713,Q7Z4L5 4 |
| Nuclear receptors metapathway 0.3176094611863874 0.902154838784741 0.3669746211976399 1.0 0.8407968330048549 51 P08183,Q16543,P48163,P09601,P23786,P11802,P11413,Q13501,O00170,Q99576,P27105,P50416,Q14914,Q9HCL2,Q99735,Q15067 16 |
| Glycogen synthesis and degradation 0.38885116561424 0.8756457284168991 0.3812226576816919 1.0 0.8521447642296643 20 P30154,Q04446,Q16537,P52789,P13807,P49841,P46976,P63151,P46020 9 |
| Allograft rejection 0.4677118313584276 0.8526077729139184 0.393876850652215 1.0 0.8599890294811641 9 P08183,P10321,P04439,P08670 4 |
| Nad metabolism 0.5760847392392792 0.846162613731257 0.3974620350069195 1.0 0.8599890294811641 5 Q8IXJ6 1 |
| Nad biosynthetic pathways 0.5760847392392792 0.846162613731257 0.3974620350069195 1.0 0.8599890294811641 5 Q8IXJ6 1 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.5683476740941253 0.8122888008030607 0.416625935197298 1.0 0.8763650006572782 5 Q9BXK5,Q07820 2 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.4603534265915477 0.8114458575955771 0.417109673441836 1.0 0.8763650006572782 9 P31751,Q05086,P42345 3 |
| Ovarian infertility 0.7425888380721319 0.8070981308239074 0.4196099489336844 1.0 0.8763650006572782 3 O75376 1 |
| Vitamin d receptor pathway 0.4068802721592943 0.7658021056344383 0.443794061144209 1.0 0.8912697070864892 13 Q96KA5,P49427,P08183,P11413,Q92604,P24941,P04080,Q92783,P20020 9 |
| Fluoropyrimidine activity 0.4196223638669851 0.7621973092961583 0.4459422517741491 1.0 0.8912697070864892 12 P31350,Q06203,Q9BZX2 3 |
| Apoptosis modulation and signaling 0.3871159892416461 0.7258943071841302 0.4679035666865738 1.0 0.9051192559583427 14 Q9NR28,Q07820,O95831 3 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.4321492935758724 0.7014694406715255 0.4830100993205952 1.0 0.9051192559583427 10 P49770,P05556,P42345,P49841,Q13418,Q96B36,P19838 7 |
| Relationship between inflammation cox2 and egfr 0.6329123365206955 0.6924964185052322 0.4886256342908048 1.0 0.9051192559583427 4 P31751 1 |
| Nanoparticle triggered autophagic cell death 0.5327786813215346 0.6591996454239396 0.5097675745920256 1.0 0.9097856792704908 5 Q14457,Q96GC9,Q9Y371 3 |
| Sting pathway in kawasakilike disease and covid19 0.6978950489178899 0.6462448589023786 0.5181207921424034 1.0 0.9097856792704908 3 Q9UHD2,Q86UT6 2 |
| Glucocorticoid receptor pathway 0.4604567216516955 0.6436765248616971 0.5197852156059308 1.0 0.9097856792704908 7 Q99576 1 |
| Spinal cord injury 0.3517735309374589 0.6406589166817824 0.5217443118320797 1.0 0.9097856792704908 22 P14174,Q9NQC3,Q08209,P08670 4 |
| Purine metabolism and related disorders 0.3676209112960868 0.6098342640917589 0.5419716014471243 1.0 0.9229987215453724 15 P00813,P20839 2 |
| Nocgmppkg mediated neuroprotection 0.4519604213514857 0.6019648100656342 0.5471975617748113 1.0 0.9267301324765606 7 Q13555 1 |
| Nitric oxide metabolism in cystic fibrosis 0.6039669359888385 0.5840474972309005 0.5591883567342544 1.0 0.9289249204765756 4 O60678 1 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3178612375266929 0.5768065788296656 0.5640701248587576 1.0 0.9295891695357767 33 Q16850,P37268,P04035,Q14534,Q9HCL2 5 |
| Praderwilli and angelman syndrome 0.423890741663773 0.5721034165863429 0.5672519146243991 1.0 0.9295891695357767 8 P11802,Q15154,Q05086,Q7L576 4 |
| Sars coronavirus and innate immunity 0.6718620197767289 0.5568445465337264 0.5776336450963475 1.0 0.9295891695357767 3 Q7Z434 1 |
| Liver x receptor pathway 0.6639004149377605 0.5560427693765179 0.578181617302542 1.0 0.9295891695357767 2 O00767 1 |
| Proteasome degradation 0.2986266569343864 0.5505258651769198 0.5819587412859324 1.0 0.9295891695357767 42 P28070,P61289,P49721,P20618,P51665,P46934,Q99436,P28074,P28072,P04439,Q9UL46 11 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.668247850578124 0.5447398602106901 0.5859324460897861 1.0 0.9295891695357767 3 P49841,P42345 2 |
| Purine metabolism 0.4021512678092038 0.5338432251675577 0.5934500050942124 1.0 0.9295891695357767 10 P00813 1 |
| Ketogenesis and ketolysis 0.4565982871407475 0.523766758989206 0.6004407761849104 1.0 0.9312958977561876 6 O43772,P23786,P35610 3 |
| Eicosanoid metabolism via lipooxygenases lox 0.4548275810859974 0.5158929999637882 0.6059291433894887 1.0 0.9342902566821014 6 P09960,Q15067 2 |
| Sarscov2 b117 variant antagonises innate immune activation 0.651700747387737 0.490394798063032 0.6238545569852978 1.0 0.9482589266176524 3 Q7Z434 1 |
| Drug induction of bile acid pathway 0.6428571428571441 0.4839037061328237 0.6284542100325918 1.0 0.9509175955648672 2 P08183 1 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.3731862188290826 0.4818068725523229 0.6299431467900947 1.0 0.9509175955648672 12 Q9BWD1,P04035,O95749,P37268 4 |
| Tryptophan metabolism 0.3473959566494021 0.4756499788268018 0.6343237628266336 1.0 0.9509175955648672 15 P51648 1 |
| Ciliopathies 0.3271991548053548 0.4529329558335179 0.6505970192768165 1.0 0.9509175955648672 22 Q13432,Q9UBB4,Q10713,Q7Z4L5 4 |
| Insulin signaling in adipocytes normal condition 0.5666509506365135 0.4515056379558015 0.6516251625279865 1.0 0.9509175955648672 4 P31751,P42345 2 |
| Insulin signaling in adipocytes diabetic condition 0.5666509506365135 0.4515056379558015 0.6516251625279865 1.0 0.9509175955648672 4 P31751,P42345 2 |
| Riboflavin and coq disorders 0.4181945858529984 0.4415486106495243 0.658815877938369 1.0 0.9509175955648672 7 Q8NI60,O75208 2 |
| Nuclear receptors in lipid metabolism and toxicity 0.6283343212803805 0.4363634967957873 0.6625730190823709 1.0 0.9509175955648672 2 P08183 1 |
| Ppar signaling pathway 0.3394136022042725 0.4363416448097164 0.6625888711299601 1.0 0.9509175955648672 16 P23786,Q15067 2 |
| Energy metabolism 0.3539518667908273 0.4336498158836948 0.6645427540243407 1.0 0.9509175955648672 13 Q13555,Q9NTG7 2 |
| Inclusion body myositis 0.5594734393290043 0.427172895660127 0.669253401556593 1.0 0.9509175955648672 4 P05067,Q92542 2 |
| Estrogen receptor pathway 0.6315948093049256 0.4269771937746894 0.6693959389831632 1.0 0.9509175955648672 3 Q9HCL2 1 |
| Biomarkers for pyrimidine metabolism disorders 0.3935324628956868 0.418932923044196 0.675265155017313 1.0 0.954099797933636 8 P31350,Q9H0P0,Q02127 3 |
| Quercetin and nfkb ap1 induced apoptosis 0.6179608772969781 0.4036442254769907 0.6864743592150977 1.0 0.9564651173858224 2 P19838 1 |
| G1 to s cell cycle control 0.304577840873762 0.3915262169595573 0.6954083138516483 1.0 0.9597382507192675 28 O43913,P25205,P11802,P49643,Q9UBD5,Q9Y619,P49736,Q99640,O75419,Q14566 10 |
| Mitochondrial long chain fatty acid betaoxidation 0.3461586658685695 0.3873786128023518 0.6984759347318779 1.0 0.9597382507192675 13 P33121,P23786,Q9BY49,P50416,O43772,P40939 6 |
| Glycosylation and related congenital defects 0.3834563186984799 0.3703126462346772 0.7111495522174427 1.0 0.9694594792560656 8 Q9Y5P6,Q2TAA5 2 |
| Type i interferon induction and signaling during sarscov2 infection 0.5316698161631367 0.3371691114955571 0.7359894208179514 1.0 0.980855981244786 4 Q7Z434 1 |
| Nrf2 pathway 0.3057206153503312 0.3353822722899942 0.7373367390351022 1.0 0.980855981244786 24 P09601,P11413,Q99735 3 |
| Calcium regulation in cardiac cells 0.3013608323833147 0.3256387370214374 0.7446977003868447 1.0 0.980855981244786 25 P16615,Q13555 2 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.3543015511928246 0.3221577290765864 0.7473332060178759 1.0 0.980855981244786 11 Q08209 1 |
| Head and neck squamous cell carcinoma 0.3342677932409271 0.3187236378198163 0.7499360883681196 1.0 0.980855981244786 13 P31751,P11802,P42345,P19838 4 |
| Apoptosis modulation by hsp70 0.4439488054371562 0.311661671531364 0.755297659720529 1.0 0.9812475753086964 5 O95831,P19838,P49327 3 |
| Mecp2 and associated rett syndrome 0.3086428437532457 0.2781518974696885 0.7808957585188072 1.0 0.9881950960293228 19 P31943,O75376,Q05086,P42345,Q99640,P52597,Q03518 7 |
| Pparalpha pathway 0.3762816524647796 0.2597187712980379 0.7950807119913046 1.0 0.9881950960293228 7 P23786,P50416 2 |
| Pyrimidine metabolism and related diseases 0.35892220946488 0.2579995791826402 0.7964072319973161 1.0 0.9881950960293228 8 P31350,Q9H0P0,P27708,Q02127 4 |
| Mevalonate pathway 0.3907869339790749 0.2528809470100411 0.8003602131342575 1.0 0.9910774125980216 6 P04035 1 |
| Myometrial relaxation and contraction pathways 0.3008475218838194 0.2493672586409195 0.8030767091247855 1.0 0.9912124615222226 21 P16615,Q13555 2 |
| Physicochemical features and toxicityassociated pathways 0.3043311630201845 0.2374417141997843 0.812314131581503 1.0 0.9925182019215096 18 Q13153,Q14012,P07197 3 |
| Interactions between loxl4 and oxidative stress pathway 0.4964342981547523 0.2344499693618869 0.8146356694724006 1.0 0.9925182019215096 4 Q16543,Q8TAG9 2 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.31279508688593 0.2020292882922348 0.8398938275094863 1.0 1.0 13 Q9NVV0,O75718,P13674,O15460 4 |
| Supression of hmgb1 mediated inflammation by thbd 0.5406046235921771 0.1984189548580997 0.8427172884284753 1.0 1.0 2 P19838 1 |
| Nucleotide metabolism 0.3005539951125935 0.1907370414287214 0.8487316165549925 1.0 1.0 15 P31350,P54098,P19623,P20839 4 |
| Translation inhibitors in chronically activated pdgfra cells 0.2935765301802572 0.172706494626249 0.8628821385359755 1.0 1.0 18 Q14240,Q15418,P23588,P42345,P31751 5 |
| Circadian rhythm genes 0.2576983535856435 0.1688899995898601 0.8658831653733843 1.0 1.0 44 P23246,Q9NRV9,P00813,O75376,P54802 5 |
| Cytosolic dnasensing pathway 0.2961098405514383 0.1629212326584177 0.8705804529416343 1.0 1.0 14 Q7Z434,Q86UT6,Q9UHD2,Q9BUI4,Q13546,P19838 6 |
| Envelope proteins and their potential roles in edmd physiopathology 0.2918969865454606 0.162915193716505 0.8705852077970648 1.0 1.0 18 Q14739,O94901,P50402,P42167 4 |
| 7oxoc and 7betahc pathways 0.3349059595593711 0.1583436661497527 0.8741860015241076 1.0 1.0 8 O15118 1 |
| Aryl hydrocarbon receptor pathway wp2873 0.4572704028884958 0.1380204435426446 0.8902242605650059 1.0 1.0 4 Q16543 1 |
| Vitamin b12 metabolism 0.3294870889236141 0.1375123929910595 0.8906257976107264 1.0 1.0 8 Q96EY8,Q8WTV0 2 |
| T cell receptor and costimulatory signaling 0.3192312449510666 0.1122855375201126 0.9105970086686476 1.0 1.0 9 Q15118,P20936,P49841,P19838,Q08209 5 |
| Sarscov2 and covid19 pathway 0.4989567429077662 0.1072705510742729 0.9145743465491144 1.0 1.0 3 Q8WTV0 1 |
| Vitamin dsensitive calcium signaling in depression 0.3363472072188551 0.077539904643615 0.93819404749921 1.0 1.0 6 P11413 1 |
| Id signaling pathway 0.4665085951393023 0.0759403502314901 0.9394665546842632 1.0 1.0 2 P24941 1 |
| Mirna regulation of prostate cancer signaling pathways 0.3054070112893662 0.0741274308249887 0.9409089886583464 1.0 1.0 10 P28482,P35222,P04637,P42345,P36507,P49841,Q8NCF5,P62993,P19838 9 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.2741506003149047 0.0605529354870788 0.9517152567383826 1.0 1.0 17 Q05397,Q13501,P05067,P08670,Q13177,P19838,P16989 7 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.3052256532066488 0.0527371932477897 0.9579413043189264 1.0 1.0 8 P28482,P42345,Q96KB5,Q13131,P27361,P36507,P06730 7 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.3052256532066486 0.0527371932477888 0.9579413043189272 1.0 1.0 8 Q16539,P51812,P28482,Q15418,P36507,P27361,P06730 7 |
| Autosomal recessive osteopetrosis pathways 0.4507294110465425 0.0421681182867637 0.9663646778652872 1.0 1.0 3 P51798 1 |
| Apoptosis 0.283575954049113 0.0342928617251157 0.972643617041568 1.0 1.0 12 Q9NR28 1 |
| Erbb signaling pathway 0.266736457459355 0.0333845841551684 0.9733679028728744 1.0 1.0 19 P31751,Q13555 2 |
| Cell cycle 0.2397962604530723 0.0254415453826063 0.9797027733983964 1.0 1.0 53 O43913,P25205,Q12834,P11802,Q9UBD5,Q9Y619,Q9UJX6,Q9UJX3,P49841,Q99640,Q8WVM7,O75419,Q14566 13 |
| Ltf danger signal response pathway 0.400414937759338 0.0236700870353653 0.981115766405851 1.0 1.0 2 P19838 1 |
| Mapk and nfkb signaling pathways inhibited by yersinia yopj 0.400414937759338 0.0236700870353653 0.981115766405851 1.0 1.0 2 P19838 1 |
| Thyroid hormones production and peripheral downstream signaling effects 0.2657738095238119 0.0183748718392866 0.9853397984257728 1.0 1.0 16 Q16539,Q7LBC6,P28482,P35222,P17252,Q02750,O60343,P42345,P17612,P04637,O60341,Q96B36,P49841,Q9UNY4,P62993 15 |
| Amino acid metabolism pathway excerpt histidine catabolism extension 0.3841138114997053 0.0169196181994646 0.9865007419469708 1.0 1.0 2 Q8TD30 1 |
| Melanoma 0.2641446188222537 0.0111237895118898 0.9911246831279048 1.0 1.0 16 P31751 1 |
| Somatroph axis gh and its relationship to dietary restriction and aging 0.3559573206876132 0.0091606794002197 0.9926909375672835 1.0 1.0 2 P42345 1 |
| Nephrogenesis 0.3254297569650287 0.004688948153783 0.9962587743709406 1.0 1.0 2 O95747 1 |
| Bladder cancer 0.3050445103857664 0.003527523097814 0.997185449619485 1.0 1.0 6 P28482,P06400,P11802,P04637,P36507 5 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.4014230655203135 0.0021293416043473 0.9983010324930964 1.0 1.0 3 Q14145,Q15758 2 |
| Tolllike receptor signaling related to myd88 0.4005336495701197 0.0016161722661135 0.9987104816626432 1.0 1.0 3 Q9UHD2,P19838 2 |
|
|
